Hepatic metastases resection after cetuximab: are we missing something?

Lancet Oncol. 2020 May;21(5):e228. doi: 10.1016/S1470-2045(20)30144-3.

¹ Department of Medical Oncology, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France. Electronic address: ayhan.ulusakarya@aphp.fr.
² INSERM U935 Campus CNRS, Villejuif, France; North Wales Cancer Centre, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board, Bangor, UK; Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences, Warwick Medical School, Coventry, UK.
³ Department of Medical Oncology, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France.
⁴ Department of Medical Oncology, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France; Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences, Warwick Medical School, Coventry, UK.
⁵ Centre Hépato-Biliaire, Assistance Publique-Hopitaux de Paris, Paul Brousse Hospital, 94800 Villejuif, France; INSERM U935 Campus CNRS, Villejuif, France.

No abstract available

Publication types